2024 Q2 Form 10-Q Financial Statement

#000149315224019143 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $13.11M $15.67M
YoY Change -24.05% 15.52%
Cost Of Revenue $1.304M $2.142M
YoY Change -49.65% 14.08%
Gross Profit $11.80M $13.53M
YoY Change -19.54% 15.75%
Gross Profit Margin 90.05% 86.33%
Selling, General & Admin $2.588M $11.80K
YoY Change -10.48% -95.33%
% of Gross Profit 21.92% 0.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.123M $1.178M
YoY Change 1.64% 21.3%
% of Gross Profit 9.52% 8.71%
Operating Expenses $12.65M $13.80M
YoY Change -21.17% 4.76%
Operating Profit $455.1K $1.870M
YoY Change -62.36% 376.7%
Interest Expense -$304.7K -$38.05K
YoY Change -8.55% -112.32%
% of Operating Profit -66.95% -2.03%
Other Income/Expense, Net $346.8K $299.6K
YoY Change 286.61% 170.92%
Pretax Income $801.9K $2.170M
YoY Change -38.25% 331.45%
Income Tax $269.1K $500.1K
% Of Pretax Income 33.55% 23.04%
Net Earnings $532.8K $1.670M
YoY Change -10.81% 309.41%
Net Earnings / Revenue 4.07% 10.66%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.861B shares 1.861B shares
Diluted Shares Outstanding 2.897B shares 3.089B shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.19M $24.43M
YoY Change 22.21% 27.02%
Cash & Equivalents $23.66M $24.43M
Short-Term Investments
Other Short-Term Assets $86.28K $232.8K
YoY Change -95.53% -88.8%
Inventory $0.00 $0.00
Prepaid Expenses $186.1K $643.8K
Receivables $1.872M $1.873M
Other Receivables $538.6K $0.00
Total Short-Term Assets $29.47M $27.80M
YoY Change 17.12% 10.4%
LONG-TERM ASSETS
Property, Plant & Equipment $4.061M $5.361M
YoY Change -53.84% -34.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $41.95K $2.589M
YoY Change -98.36% -2.98%
Other Assets $102.8K $2.675M
YoY Change -96.39% -9.91%
Total Long-Term Assets $4.164M $8.036M
YoY Change -64.24% -27.75%
TOTAL ASSETS
Total Short-Term Assets $29.47M $27.80M
Total Long-Term Assets $4.164M $8.036M
Total Assets $33.64M $35.84M
YoY Change -8.62% -1.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.120M $8.399M
YoY Change 81.5% 83.57%
Accrued Expenses $272.6K $206.6K
YoY Change 6.64% -2.4%
Deferred Revenue $2.019M $2.707M
YoY Change -27.08% 0.66%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $465.9K $569.4K
YoY Change -84.15% -80.62%
Total Short-Term Liabilities $12.64M $14.84M
YoY Change 2.53% 21.86%
LONG-TERM LIABILITIES
Long-Term Debt $495.8K $498.4K
YoY Change -87.8% -89.61%
Other Long-Term Liabilities $2.620M $1.247M
YoY Change 149.34% 37.31%
Total Long-Term Liabilities $3.116M $3.880M
YoY Change -39.09% -32.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.64M $14.84M
Total Long-Term Liabilities $3.116M $3.880M
Total Liabilities $15.75M $18.72M
YoY Change -9.68% 4.25%
SHAREHOLDERS EQUITY
Retained Earnings -$85.78M -$86.11M
YoY Change -3.61% -3.66%
Common Stock $1.861M $1.861M
YoY Change -29.41% -29.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.88M $17.12M
YoY Change
Total Liabilities & Shareholders Equity $33.64M $35.84M
YoY Change -8.62% -1.29%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $532.8K $1.670M
YoY Change -10.81% 309.41%
Depreciation, Depletion And Amortization $1.123M $1.178M
YoY Change 1.64% 21.3%
Cash From Operating Activities $531.9K $4.800M
YoY Change -87.88% -1303.96%
INVESTING ACTIVITIES
Capital Expenditures $3.460K $2.903K
YoY Change -99.81% -99.53%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.460K -$2.903K
YoY Change -99.8% -99.53%
FINANCING ACTIVITIES
Cash Dividend Paid $174.8K
YoY Change 8.85%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.301M -$1.357M
YoY Change 106.85% 116.71%
NET CHANGE
Cash From Operating Activities 531.9K $4.800M
Cash From Investing Activities -3.460K -$2.903K
Cash From Financing Activities -1.301M -$1.357M
Net Change In Cash -773.0K $3.440M
YoY Change -138.79% -309.4%
FREE CASH FLOW
Cash From Operating Activities $531.9K $4.800M
Capital Expenditures $3.460K $2.903K
Free Cash Flow $528.5K $4.797M
YoY Change -79.66% -571.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
usd
CY2024Q1 INVU Gain Loss On Disposal Of Fixed Assets
GainLossOnDisposalOfFixedAssets
usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2024Q1 INVU Increase Decrease In Income Tax Paid In Advance
IncreaseDecreaseInIncomeTaxPaidInAdvance
usd
CY2024Q1 INVU Increase Decrease Customer Advances
IncreaseDecreaseCustomerAdvances
usd
CY2023Q1 INVU Payments For Shares Repurchased From Related Parties
PaymentsForSharesRepurchasedFromRelatedParties
usd
CY2024Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 INVU Common Stock Repurchased For Payables
CommonStockRepurchasedForPayables
usd
CY2024Q1 INVU Derivative Liability Extinguished With Warrant Exercise
DerivativeLiabilityExtinguishedWithWarrantExercise
usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
usd
CY2024Q1 INVU Derivative Liability Recorded On New Instruments
DerivativeLiabilityRecordedOnNewInstruments
usd
CY2024Q1 INVU Derivative Liability Reduced By Warrant Exercise
DerivativeLiabilityReducedByWarrantExercise
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2024Q1 INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
CY2024Q1 INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2024Q1 INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-27019
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Investview, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0369205
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
521 West Lancaster Avenue
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Second Floor
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Haverford
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19041
CY2024Q1 dei City Area Code
CityAreaCode
732
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
889-4300
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1860981786 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24432226 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20912276 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
150022 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
230354 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
643799 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
492607 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
2341037 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2232725 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
232834 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
585632 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
27799918 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
24453594 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5361296 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6536823 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
86034 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
110427 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2589062 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2588127 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2675096 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2698554 usd
CY2024Q1 us-gaap Assets
Assets
35836310 usd
CY2023Q4 us-gaap Assets
Assets
33688971 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8399052 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5854093 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
104308 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
187419 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1502815 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1004535 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2707418 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2703398 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5658 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5732 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
246297 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
256392 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
102290 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109628 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1203577 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1203247 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
569410 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
715127 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14840825 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12039571 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3208 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6048 usd
CY2024Q1 INVU Accrued Liabilities Long Term
AccruedLiabilitiesLongTerm
2132275 usd
CY2023Q4 INVU Accrued Liabilities Long Term
AccruedLiabilitiesLongTerm
1189643 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1246559 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1162349 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
498426 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
501062 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3880468 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2859102 usd
CY2024Q1 us-gaap Liabilities
Liabilities
18721293 usd
CY2023Q4 us-gaap Liabilities
Liabilities
14898673 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
252192 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
252192 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
252192 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
252192 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
252 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
252 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1860981786 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1860981786 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2333356496 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2333356496 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1860982 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2333356 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101388795 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104056807 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23218 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23218 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86111794 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87576899 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
17115017 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18790298 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35836310 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33688971 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15671917 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13566608 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2142334 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1877928 usd
CY2024Q1 INVU Commissions
Commissions
7275210 usd
CY2023Q1 INVU Commissions
Commissions
6529093 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11795 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
252434 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
1628970 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
1924197 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
406529 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
493884 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-20270 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2336655 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2076430 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
13801493 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
13174236 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1870424 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
392372 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
74 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
8756 usd
CY2024Q1 INVU Realized Gain Loss On Cryptocurrency
RealizedGainLossOnCryptocurrency
276227 usd
CY2023Q1 INVU Realized Gain Loss On Cryptocurrency
RealizedGainLossOnCryptocurrency
242572 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
337635 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
172623 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
299591 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
110584 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2170015 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
203059 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1669940 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
502956 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500075 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95062 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1669940 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
407894 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
204835 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
204835 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1465105 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4020 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
615062 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4675 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4623 usd
CY2024Q1 INVU Increase Decrease In Interest Payable Related Parties Net
IncreaseDecreaseInInterestPayableRelatedPartiesNet
225459 usd
CY2023Q1 INVU Increase Decrease In Interest Payable Related Parties Net
IncreaseDecreaseInInterestPayableRelatedPartiesNet
225459 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
407894 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2053046229 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2636275719 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3089474800 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3672704290 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17374576 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
768613 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
23 usd
CY2023Q1 INVU Adjustments To Additional Paid In Capital Derivative Liability Extinguished For Warrants Exercised
AdjustmentsToAdditionalPaidInCapitalDerivativeLiabilityExtinguishedForWarrantsExercised
3 usd
CY2023Q1 us-gaap Dividends
Dividends
204835 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
407894 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
18346274 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18790298 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18790298 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
430760 usd
CY2024Q1 INVU Stock Repurchased And Retired From Related Parties During Period Value
StockRepurchasedAndRetiredFromRelatedPartiesDuringPeriodValue
-3571146 usd
CY2024Q1 us-gaap Dividends
Dividends
204835 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1669940 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
17115017 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
17115017 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1669940 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
407894 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1178430 usd
CY2023Q1 us-gaap Depreciation
Depreciation
971526 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
84210 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
83285 usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
430760 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
768613 usd
CY2024Q1 INVU Gain Losson Lease Cost Netof Repayment
GainLossonLeaseCostNetofRepayment
-14215 usd
CY2023Q1 INVU Gain Losson Lease Cost Netof Repayment
GainLossonLeaseCostNetofRepayment
-22461 usd
CY2023Q1 INVU Gain Loss On Disposal Of Fixed Assets
GainLossOnDisposalOfFixedAssets
-20270 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
74 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
8756 usd
CY2024Q1 INVU Realized Gain Loss On Cryptocurrency
RealizedGainLossOnCryptocurrency
276227 usd
CY2023Q1 INVU Realized Gain Loss On Cryptocurrency
RealizedGainLossOnCryptocurrency
242572 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
108312 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
348609 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-51445 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
151192 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
656129 usd
CY2023Q1 INVU Increase Decrease In Income Tax Paid In Advance
IncreaseDecreaseInIncomeTaxPaidInAdvance
85062 usd
CY2024Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
935 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
2194987 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-550088 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
26359 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
676274 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-150720 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
498280 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
10000 usd
CY2023Q1 INVU Increase Decrease Customer Advances
IncreaseDecreaseCustomerAdvances
-36221 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4799611 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-398653 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2903 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
617760 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2903 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-617760 usd
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
225129 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
225129 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
114261 usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
240564 usd
CY2024Q1 INVU Payments For Shares Repurchased From Related Parties
PaymentsForSharesRepurchasedFromRelatedParties
842940 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
174760 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
160557 usd
CY2023Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
23 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1357090 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-626227 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3439618 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1642640 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21142630 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21488898 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24582248 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19846258 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
232440 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
232440 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1795 usd
CY2024Q1 INVU Common Stock Repurchased For Payables
CommonStockRepurchasedForPayables
3571146 usd
CY2023Q1 INVU Derivative Liability Extinguished With Warrant Exercise
DerivativeLiabilityExtinguishedWithWarrantExercise
3 usd
CY2024Q1 INVU Dividends Declared
DividendsDeclared
-204835 usd
CY2023Q1 INVU Dividends Declared
DividendsDeclared
-204835 usd
CY2024Q1 INVU Dividends Paid With Cryptocurrency
DividendsPaidWithCryptocurrency
40170 usd
CY2023Q1 INVU Dividends Paid With Cryptocurrency
DividendsPaidWithCryptocurrency
46585 usd
CY2024Q1 us-gaap Notes Issued1
NotesIssued1
38767 usd
CY2023Q1 us-gaap Notes Issued1
NotesIssued1
495784 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_800_eus-gaap--NatureOfOperations_zRXg5UIOblxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_820_zbifXyLHbW7g">ORGANIZATION AND NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investview, Inc. was incorporated on <span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_dd_c20240101__20240331_zDMbo2Rxw28a" title="Entity incorporation, date of incorporation">January 30, 1946</span>, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed <span id="xdx_900_ecustom--PercentageOnContributedShares_pid_dp_uPure_c20170329__20170401__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--WealthGeneratorsLLCMember_z1LzcAaGalmd" title="Percentage on contributed shares">100</span>% of the outstanding securities of Wealth Generators in exchange for an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesOther_c20170329__20170401__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--WealthGeneratorsLLCMember_zvDX7MK3QIEc" title="Number of shares exchanged for common stock">1,358,670,942</span> shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun-off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $<span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c20170606__20170606__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember__dei--LegalEntityAxis__custom--MarketTrendStrategiesLLCMember_zXYXjz00zXM2" title="Value pre-merger liabilities">419,139</span> in pre-merger liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We operate a diversified financial technology company that through its subsidiaries and global distribution network provides financial technology, education tools, content, research, and a digital asset technology company, which develops, operates, and supports blockchain technologies, with a focus on the Bitcoin blockchain ecosystem and the generation of digital assets. In addition, we are expanding our business into the retail brokerage and financial markets industry by integrating the online brokerage trading platform we acquired in connection with our recent acquisition of Opencash Securities, LLC (“Opencash”), with the proprietary algorithmic trading platform we acquired in September 2021. Opencash is an early-stage registered broker-dealer that plans to offer investors an online trading platform to enable self-directed retail brokerage services and develop synergies with the educational content and products offered by one of our other business units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AS OF MARCH 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1946-01-30
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24432226 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20912276 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
150022 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
230354 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24582248 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21142630 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zsxRxMaQepuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zalpUjpUXNo9">Financial Statement Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zMrvD52Iibta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zm3CVw1J1lBd">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zz5Luo94CT1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zv2UND7dcQVe">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20240331_zdowN2zHSfMc" title="Cash, FDIC insured amount">250,000</span>. As of March 31, 2024 and December 31, 2023, cash balances that exceeded FDIC limits were $<span id="xdx_90C_ecustom--CashBalancesExceededFederalDepositInsuranceCorporationLimits_iI_c20240331_zX5vqQSbdUc" title="Cash balances exceeded FDIC limits">6,834,803</span> and $<span id="xdx_907_ecustom--CashBalancesExceededFederalDepositInsuranceCorporationLimits_iI_c20231231_zu1v2hZOEu3d" title="Cash balances exceeded FDIC limits">3,778,085</span>, respectively. We have not experienced any losses relating to these concentrations in the past.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 INVU Cash Balances Exceeded Federal Deposit Insurance Corporation Limits
CashBalancesExceededFederalDepositInsuranceCorporationLimits
6834803 usd
CY2023Q4 INVU Cash Balances Exceeded Federal Deposit Insurance Corporation Limits
CashBalancesExceededFederalDepositInsuranceCorporationLimits
3778085 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
722324 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1872773 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
500000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14099598 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14096695 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8738302 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7559872 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5361296 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6536823 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1178430 usd
CY2023Q1 us-gaap Depreciation
Depreciation
971526 usd
CY2024Q1 INVU Cryptocurrencies
Cryptocurrencies
232834 usd
CY2023Q4 INVU Cryptocurrencies
Cryptocurrencies
585632 usd
CY2024Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
5658 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5658 usd
CY2023Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
5732 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5732 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
2707418 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
2703398 usd
CY2024Q1 INVU Gross Billingsreceipts
GrossBillingsreceipts
16493893 usd
CY2024Q1 INVU Refunds Incentives Credits And Chargebacks
RefundsIncentivesCreditsAndChargebacks
-821976 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15671917 usd
CY2023Q1 INVU Gross Billingsreceipts
GrossBillingsreceipts
14806019 usd
CY2023Q1 INVU Refunds Incentives Credits And Chargebacks
RefundsIncentivesCreditsAndChargebacks
-960411 usd
CY2023Q1 us-gaap Payments To Suppliers
PaymentsToSuppliers
279000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13566608 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11795 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
252434 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2142334 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1877928 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
20000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
0 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2023Q1 INVU Derivative Liability Extinguished With Warrant Exercise
DerivativeLiabilityExtinguishedWithWarrantExercise
3 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1860981786 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1860981786 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2333356496 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2333356496 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
1000000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1669940 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
407894 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
204835 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
204835 usd
CY2024Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
225129 usd
CY2023Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
225129 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1690234 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
428188 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2053046229 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2636275719 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
471428571 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
471428571 shares
CY2024Q1 INVU Incremental Common Shares Attributable To Dilutive Impact Of Nonvoting Membership Interest
IncrementalCommonSharesAttributableToDilutiveImpactOfNonvotingMembershipInterest
565000000 shares
CY2023Q1 INVU Incremental Common Shares Attributable To Dilutive Impact Of Nonvoting Membership Interest
IncrementalCommonSharesAttributableToDilutiveImpactOfNonvotingMembershipInterest
565000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3089474800 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3672704290 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.05
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1870424 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1669940 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24432226 usd
CY2024Q1 INVU Working Capital
WorkingCapital
12959093 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
232834 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
510104 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
477711 usd
CY2024Q1 INVU Convertible Notes Payable One
ConvertibleNotesPayableOne
271151 usd
CY2023Q4 INVU Convertible Notes Payable One
ConvertibleNotesPayableOne
253566 usd
CY2024Q1 INVU Convertible Notes Payable Two
ConvertibleNotesPayableTwo
465304 usd
CY2023Q4 INVU Convertible Notes Payable Two
ConvertibleNotesPayableTwo
431072 usd
CY2024Q1 INVU Working Capital Promissory Note Entered
WorkingCapitalPromissoryNoteEntered
1203577 usd
CY2023Q4 INVU Working Capital Promissory Note Entered
WorkingCapitalPromissoryNoteEntered
1203247 usd
CY2020Q2 INVU Related Party Transaction Amounts Of Advance
RelatedPartyTransactionAmountsOfAdvance
11000000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
1067836 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1216189 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
569410 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
715127 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
498426 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
501062 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5732 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
74 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5658 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
27732 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
13517 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M2D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
102509 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7833 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
110342 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4844 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
105498 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
102290 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3208 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
252192 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
252192 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
252192 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
252192 shares
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
246297 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
360416665 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.03
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1000000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.05
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.02
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
361416665 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.03
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
191666665 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.05
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M26D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M26D
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
422250 usd
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
765007 usd
CY2024Q1 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
4800000 usd
CY2024Q1 INVU Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Vesting Period Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingVestingPeriodContractualTerm
P2Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1178090 shares
CY2023Q4 INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.10
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1178090 shares
CY2024Q1 INVU Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.10
CY2023Q1 INVU Warrants Exercisable
WarrantsExercisable
1178090 shares
CY2023Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y10M24D
CY2024Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement.
CY2021Q3 INVU Business Acquisition Cost Of Acquired Entity Transaction Fair Value Discount
BusinessAcquisitionCostOfAcquiredEntityTransactionFairValueDiscount
27700000 usd
CY2024Q1 us-gaap Long Term Purchase Commitment Description
LongTermPurchaseCommitmentDescription
According to marketing and legal documents provided by such third-party provider, the product protection would allow the purchaser to protect its initial purchase price by obtaining 50% of its purchase price at five years or 100% of its purchase price at ten years.
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500075 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230 pure
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95062 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.189 pure
CY2024Q1 INVU Description Of Regulatory Capital Requirements
DescriptionOfRegulatoryCapitalRequirements
The Company’s broker-dealer subsidiary, Opencash Securities, LLC, is subject to certain net capital requirements. Opencash Securities, LLC computes its net capital under the alternative method permitted, which requires minimum net capital of the greater of $5,000 or 2% of the aggregate debit items in the reserve formula for those broker-dealers subject to Rule 15c3-3 promulgated under the Securities Exchange Act of 1934, as amended. The requirement was $5,000 for the broker-dealer at March 31, 2024. At March 31, 2024, Opencash Securities, LLC had net capital, as defined, of approximately $500 thousand, exceeding the regulatory requirement by approximately $495 thousand. Net capital requirements for the Company’s affiliated broker-dealer may increase in accordance with the rules and regulations applicable to broker-dealers to the extent Opencash Securities, LLC engages in other business activities.
CY2024Q1 us-gaap Payments For Brokerage Fees
PaymentsForBrokerageFees
5000 usd

Files In Submission

Name View Source Status
0001493152-24-019143-index-headers.html Edgar Link pending
0001493152-24-019143-index.html Edgar Link pending
0001493152-24-019143.txt Edgar Link pending
0001493152-24-019143-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
invu-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
invu-20240331_cal.xml Edgar Link unprocessable
invu-20240331_lab.xml Edgar Link unprocessable
invu-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
invu-20240331_def.xml Edgar Link unprocessable